Class 424/568 - Thyroid gland

Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the material is or is derived from
No. of patents: 24
Last issue date: 03/27/2012

Number	Title	Issue Date
8142817	Composition for restoration of age related tissue loss in the face or selected areas of the body A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and hyaluronic acid as a carrier into the dermis, the hypodermis, or both...	03/27/2012
7198801	Formulations for transdermal or transmucosal application The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty al...	04/03/2007
6706255	Liquid pharmaceutical compositions comprising thyroid hormones Liquid pharmaceutical compositions comprising at least one thyroid hormone, ethanol, a pH adjusting agent, and water are disclosed. The compositions may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray, and are useful in the t...	03/16/2004
6528059	Thyroid peroxidase epitopic regions Specific epitopic regions of thyroid peroxidase (TPO), a thyroid specific membrane autoantigen, have been identified within amino acid residues 456 to 933, 457 to 633, 513 to 633, and 633 to 933 of the protein (SEQ ID NO:2), with at least one distinct bin...	03/04/2003
6500925	Human thyroid protein ZSIG45 The present invention relates to polynucleotide and polypeptide molecules for zsig45, a novel human protein expressed in thyroid. The polypeptides, and polynucleotides encoding them, may be used for detecting human disease states and chromosomal abnormali...	12/31/2002
6458842	Liquid pharmaceutical compositions comprising thyroid hormones There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition ...	10/01/2002
6123918	Hyperolius argus endocrine screen test Compounds and samples may be screened for estrogenic, androgenic, and thyroid hormone activity simultaneously, by administering the compound or sample to larval amphibians or tissue obtained therefrom, particularly Hyperolius argus, prior to the end of me...	09/26/2000
6054142	Biocompatible devices with foam scaffolds A biocompatible cell device having an internal foam scaffold to provide a growth surface for encapsulated cells which produce a biologically active molecule....	04/25/2000
5928670	Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...	07/27/1999
5855920	Total hormone replacement therapy A hormone replenishment method particularly useful in maintaining the body's neuroendocrine clock at optimal levels and combating conditions associated with advancing age is disclosed. The method includes determining that the level of human growth hormone...	01/05/1999
5851986	Promoting bone formation and inhibiting bone resorption with high mobility group protein-1 (HMG-1) A method for promoting osteoblast proliferation or inhibiting bone resorption comprising administering to a subject in need thereof, a composition comprising High Mobility Group Protein (HMG-1) is disclosed....	12/22/1998
5846548	Combined administration of mitogenic immumo stimulator and a thymomimetic A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance....	12/08/1998
5789387	Methods and compositions for treating fungal infections in mammals Methods of treating fungal infections are disclosed. The methods comprise administering a chitin synthesis inhibitor to a mammal in a continuous fashion so that at least a minimum effective concentration is maintained in the mammal's plasma or in a target...	08/04/1998
5738878	Process for making intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...	04/14/1998
5560936	Intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...	10/01/1996
5449522	Pharmaceutical composition for immunoenhancement therapy This invention provides an immunoenhancement or immunepotentiation therapy comprising administration of potassium, insulin, glucose and, optionally, thyroid, a cholinergic agent and bicarbonate. Therapeutic compositions comprising the above components in ...	09/12/1995
5279836	Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaeutical composition thereof A new use of calcitonin, as an active principle, is provided for the preparation of topically appliable medications in the treatment of pre-senile and senile idiopathic cataract; and a pharmaceutical composition containing elcatonin as active principle fo...	01/18/1994
5198216	Performance enhancing compositions of matter, and methods of preparing and utilizing same A composition for enhancing the performance of animals, such as horses or dogs, is composed of adrenal and pituitary raw tissue concentrates, vitamin C, bioflavonoid complex, pantothenic acid, methionine, choline, vitamin B1, vitamin B2, vitamin B6, niaci...	03/30/1993
5168102	Endocrine manipulation to improve body composition of poultry The body composition of poultry is improved by a hormonal strategy that includes the step of increasing plasma levels of thyroid hormone to about 150-250% (normal endogeneous T3 hormone level=100%) during essentially the finishing phase (e.g., ...	12/01/1992
5162302	Endocrine manipulation to improve body composition of poultry The body composition of poultry is improved by a hormonal strategy that includes the steps of (a) increasing plasma levels of thyroid hormone to at least about 150% (normal endogenous T3 hormone level=100%) during essentially the finishing phas...	11/10/1992
5057324	Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of kallikrein, thus is useful as drugs such as antiinflammatory, ana...	10/15/1991
4985254	Method of treating ischemic diseases The present invention relates to physiologically active substances extracted from infected tissues inoculated with a poxvirus. The substances of the present invention have excellent actions to improve blood flow and recover functions of diseased tissues, ...	01/15/1991
4749522	Supercritical fluid extraction of animal derived materials Supercritical fluids (SCF) are found to be useful in extracting desired materials from animal tissues, cells, and organs. By varying the choice of SCF, experimental conditions, and animal source material, one may obtain lipids, proteins, nucleotides, sacc...	06/07/1988

PatentStorm

Quotables

PatentStorm News

Class 424/568 - Thyroid gland